Sanviora Lifecare is a pharmaceutical group engaged in manufacturing, the global supply of quality-assured medicines, long-term investments in healthcare distribution, and regulatory market access.
Sanviora Lifecare was founded on deep experience in pharmaceutical manufacturing, distribution, and international trade — anchored in India, home to the world's largest generic medicines industry.
We operate as a group: manufacturing across four WHO-GMP approved facilities with capability spanning nearly every major dosage form; supplying finished formulations to licensed partners in 52 countries; taking long-term equity positions in distribution businesses; and carrying products through national regulatory registration to the patients who need them.
We are deliberately conservative in what we claim and rigorous in what we deliver. In pharmaceuticals, trust is the entire product — and it compounds.
No product moves without valid registration, complete batch documentation, and a certificate of analysis. There are no exceptions to this sequence.
We structure long-term agreements with manufacturers, distributors, and institutions — with governance, transparency, and aligned incentives on both sides.
Our investments are made to be owned for decades, not flipped. We bring capital, product pipeline, and disciplined oversight to the businesses we back.
Four WHO-GMP approved manufacturing facilities with capability across nearly every major dosage form — supplying licensed partners and contract manufacturing clients worldwide.
Long-term equity partnerships with pharmaceutical distribution and healthcare businesses in high-growth markets.
Dossier development and product registration with national regulatory authorities, managed through the full product lifecycle.
Portfolios spanning essential medicines and specialty categories, matched to the disease burden of each market we serve.
Antibiotics & antifungals
ACTs & prophylaxis
Hypertension & lipid care
Oral antidiabetics
PPIs, antacids & ORS
Analgesics & NSAIDs
Topicals & antifungal care
Multivitamins & supplements
Portfolio composition varies by market in accordance with national product registrations. Product information is provided to licensed healthcare businesses and institutions only.
Every engagement — supply, investment, or registration — runs on the same non-negotiable quality architecture.
Four manufacturing facilities holding WHO-GMP approval and compliant with India's Revised Schedule M, with site documentation maintained for every product.
Registration dossiers compiled to CTD/ACTD standards, with stability data appropriate to the climatic zone of each destination market.
Certificate of analysis with every batch, serialized documentation, and cold-chain logistics where product profiles require it.
Post-market surveillance coordination and adverse event reporting pathways established with partners in every market of operation.
Group-wide anti-bribery, sanctions screening, and trade compliance standards embedded in every partnership agreement we sign.
Our manufacturing is anchored in India — the pharmacy of the world — and our focus is the set of high-growth markets where access to quality-assured, affordable medicines is still being built.
We enter markets through licensed local partners, invest in the businesses that serve them, and stay.
We work with a deliberately small number of partners, and we choose them carefully. If that sounds like how you work, we should talk.
